TradeLink Capital’s Quest Diagnostics DGX Stock Holding History

TradeLink Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,815	Closed	-$229K	–	97
2016 Q2	$229K	Sell	2,815 -2,265	-45%	-$172K	1.09%	40
2016 Q1	$363K	Buy	5,080 +1,904	+60%	+$128K	0.67%	28
2015 Q4	$226K	Buy	+3,176	New	+$214K	0.47%	75
2015 Q3	–	Sell	-3,176	Closed	-$230K	–	117
2015 Q2	$230K	Hold	3,176	–	–	0.34%	86
2015 Q1	$244K	Sell	3,176 -829	-21%	-$59.4K	0.62%	39
2014 Q4	$268K	Buy	+4,005	New	+$253K	0.36%	58
2013 Q4	–	Sell	-400	Closed	-$25K	–	205
2013 Q3	$25K	Buy	+400	New	+$23.9K	0.06%	218

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

TradeLink Capital's DGX Position: Q3 2016 in Review

TradeLink Capital sold out of Quest Diagnostics (DGX) in Q3 2016, closing a stake of 2,815 shares — an estimated $229K sold.

TradeLink Capital first reported a position in DGX in Q3 2013 and held it in 7 quarters. The position peaked at $363K in Q1 2016. 560 funds tracked by Wall St. Rank hold DGX as of Q3 2016.

TradeLink Capital reported no remaining Quest Diagnostics position as of Q3 2016 after selling out during the quarter.
TradeLink Capital sold 2,815 Quest Diagnostics shares in Q3 2016, an estimated $229K.
TradeLink Capital first reported a position in Quest Diagnostics in Q3 2013 and held it in 7 quarters.
TradeLink Capital's Quest Diagnostics position peaked at $363K in Q1 2016.
560 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2016.

Based on TradeLink Capital's 13F filing for Q3 2016, filed 2 Nov 2016.